Society for Endocrinology - a world-leading authority on hormones

Amylin Pharmaceuticals, Inc., Eli Lilly and company receive EU OK for new Byetta use (BioSpace, 23 March 2012)

27 Mar 2012


The European Commission has accepted an extension to the marketing authorisation for type 2 diabetes treatment exenatide (Byetta) as an adjunctive therapy to basal insulin, with or without metformin and/or pioglitazone (Actos).

Full article